New therapeutic targets

P. J. Barnes (London, United Kingdom)

Source: Annual Congress 2007 - COPD – a disease of accelerated ageing?

Session: COPD – a disease of accelerated ageing?
Session type: Hot topics
Number: 187

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. J. Barnes (London, United Kingdom). New therapeutic targets. Annual Congress 2007 - COPD – a disease of accelerated ageing?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

New pathways, new targets Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017
New therapeutic strategies in BOS Source: Annual Congress 2007 - Bronchiolitis obliterans syndrome (BOS) after lung transplantation: new kids on the block Year: 2007
New targets for drug development in asthma Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008
New and repurposed drugs Source: Eur Respir Monogr 2018; 82: 179-204 Year: 2018
New mechanisms and targets in COPD Source: International Congress 2014 – ERS/CTS China Day: advances in asthma and COPD Year: 2014
Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019
New targets for CF therapies: hyperosmolar agents Source: Annual Congress 2011 - New promising ways to treat cystic fibrosis Year: 2011
Pathophysiology and potential future therapeutic targets using preclinical models of COVID-19 Source: ERJ Open Res, 6 (4) 00405-2020; 10.1183/23120541.00405-2020 Year: 2020
New possibilities in exposure assessment for microbial agents Source: ERS Research Seminar 2015 Year: 2015
New perspectives in PGD prevention and treatment Source: School Course 2012 - Lung Transplantation Year: 2012
New treatment approaches for IPF Source: International Congress 2016 – ME2 New treatment approaches for idiopathic pulmonary fibrosis Year: 2016
Clinical implications and novel therapies Source: International Congress 2018 – Accelerated ageing in lungs Year: 2018
How to disrupt malicious LC-fILD pathways: antifibrotic agents as a promising therapeutic approach Source: Virtual Congress 2021 – Lung cancer and fibrotic interstitial lung diseases: a challenging association for pulmonologists Year: 2021
Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008